That’s crazy it hit $11
Recent TPST News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/29/2024 08:15:40 PM
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 10/10/2024 11:30:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 11:16:01 AM
- Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial • GlobeNewswire Inc. • 10/10/2024 11:01:00 AM
- Tempest Extends Limited Duration Stockholder Rights Plan • GlobeNewswire Inc. • 10/10/2024 11:00:00 AM
- Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/20/2024 08:30:00 PM
- Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs • GlobeNewswire Inc. • 09/18/2024 12:00:00 PM
- Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/23/2024 08:30:00 PM
- Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance • GlobeNewswire Inc. • 08/21/2024 12:00:00 PM
- Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma • GlobeNewswire Inc. • 08/15/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/13/2024 12:03:15 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/13/2024 12:59:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/09/2024 07:41:28 PM
- Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/08/2024 08:56:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:44:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:33:48 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/19/2024 08:31:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 08:15:11 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/20/2024 12:32:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:13:58 PM
- Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm • GlobeNewswire Inc. • 06/20/2024 12:00:00 PM
- Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma • GlobeNewswire Inc. • 06/18/2024 10:22:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:05:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:41:58 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM